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Abstract: To determine whether a subset of primary extramammary
Paget disease (EMPD) may originate in anogenital mammary-like
glands (AGMLG), the authors studied 181 specimens of EMPD,
detailing alterations in AGMLG. The latter were identiﬁed in 33
specimens from 31 patients. All patients were women, ranging in age
from 38 to 93 years (median, 65y). In all cases, lesions involved the
vulva and in 1 patient the perianal skin was aﬀected. Histopatho-
logically, AGMLG manifested changes identical to columnar cell
change (CCC) (87.1%), usual ductal hyperplasia (22.6%), columnar
cell hyperplasia (CCH) (9.7%), oxyphilic (apocrine) metaplasia
(6.5%), and atypical duct hyperplasia (3.2%). Four cases (12.9%),
in addition to intraepidermal carcinoma, harbored invasive carci-
noma. In all 4 of these, AGMLG displayed a range of alterations
including ductal carcinoma in situ, CCC, and CCH. Three further
cases (9.7%) showed ductal carcinoma in situ without any deﬁnite
invasive carcinoma. Colonization of AGMLG by neoplastic Paget
cells was noted in 6 cases. As CCC and CCH may be encountered
in normal AGMLG, these alterations are unlikely to play a
signiﬁcant role in the pathogenesis of the disease. However, by
analogy with mammary Paget disease, rare cases of primary EMPD
may originate in AGMLG with a subsequent upward migration of
the neoplastic cells into the epidermis and possible later breach
through the basal membrane. Usual ductal hyperplasia and atypical
duct hyperplasia can then be regarded as earlier precursor lesions,
linking both ends of the spectrum.
Key Words: anogenital mammary-like glands, extramammary Paget
disease, vulva, columnar cell change, columnar cell hyperplasia,
ductal hyperplasia, mammary-type carcinoma
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Extramammary Paget disease (EMPD) is a rare neo-plasm usually involving the anogenital area, most
commonly the vulva.1 EMPD can be divided into primary
and secondary forms, the latter representing intra-
epithelial spread of an underlying carcinoma arising in the
urogenital or gastrointestinal tracts.2–5 The histogenesis
of primary EMPD is uncertain. Cutaneous adnexa, clear
cells of Toker, pluripotent stem cells, and anogenital
mammary-like glands (AGMLG) have been proposed as
possible sites of origin.2,6–18
Unlike in mammary Paget disease (MPD), underlying
ductal carcinoma in situ (DCIS) or invasive mammary-type
carcinoma are rarely associated with primary EMPD,2,19–21
but, when present, they raise the likelihood that the patho-
genesis of EMPD in these cases may be identical
to that of MPD.2 In addition to DCIS, AGMLG in cases
of primary EMPD may show changes identical to those
aﬀecting ducts in the breast, including columnar cell change
(CCC), columnar cell hyperplasia (CCH), usual ductal
hyperplasia (UDH), and atypical duct hyperplasia (ADH).2,7
Further, AGMLG may represent a path for carcinomatous
spread into deeper tissues.2,7,22
The goals of our study were to identify and describe
the spectrum of involvement of AGMLG and their ducts
in cases of primary anogenital EMPD, and to determine
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whether a subset of primary EMPD may originate in
AGMLG, analogous to breast carcinoma.
MATERIALS AND METHODS
Case Selection
A search in the consultation, routine institutional,
and personal ﬁles of the authors between 1993 and 2016
years yielded 202 cases coded as EMPD. Histologic slides
were reviewed along with the available clinical information
obtained from patients’ medical records to conﬁrm the
location and the clinicopathologic context. Only cases of
primary anogenital EMPD were included. Excluded from
the study were 21 cases of secondary EMPD arising
from carcinomas of other primary sites (rectum, urethra,
prostate, etc.) and cases with insuﬃcient clinical data.
Light Microscopy
The study was based on the assessment of hema-
toxylin and eosin–stained slides. All specimens were local
resections, wide surgical excisions, or vulvectomies. We
determined the presence and nature of involvement
of AGMLG and their ducts in 181 specimens from 150
patients. Of the 181 specimens, 102 were wide surgical
excisions, local resections, or vulvectomies (the number of
tissue blocks ranged from 1 to 59; median, 10) and 79
were small specimens (punch, or small incisional biopsies,
with a single block per case).
The following features were assessed using the same
criteria applied in breast pathology23–25: oxyphilic metaplasia,
CCC, CCH, UDH, ADH, DCIS, and colonization of
AGMLG by carcinoma cells. Oxyphilic metaplasia manifests
as cells with eosinophilic, glassy cytoplasm, which may have
mildly pleomorphic nuclei and conspicuous nucleoli. CCC
presents as variably dilated lumina lined by 1 to 2 layers of
columnar epithelial cells oriented perpendicularly to the
basement membrane and which have apical cytoplasmic blebs
or snouts. CCH has variably dilated lumina lined by >2
layers of columnar epithelial cells as described for CCC. UDH
shows solid or fenestrated intralumimal streaming cellular
proliferation without atypia. ADH was deﬁned as a marked
intraluminal proliferation of uniform cuboidal epithelial cells
with increased nuclear to cytoplasmic ratio, forming complex
architectural patterns including micropapillae, true papillae,
cribriform spaces with Roman bridges but with mild or no
cytologic atypia.2 DCIS was deﬁned according to Rosai,
including papillary, comedocarcinoma, solid, cribriform,
micropapillary, clinging, and cystic hypersecretory variants.23
Grading of DCIS of AGMLG was according to published
criteria.26 For EMPD having both invasive carcinoma
and DCIS, grading of the invasive carcinoma was performed
according to the Nottingham system (Elston-Ellis mod-
iﬁcation of Scarﬀ-Bloom-Richardson grading system).25
All the specimens were reviewed by a general
pathologist (A.M.K.), dermatopathologist (D.V.K.), and
an expert in mammary pathology (M.M.). The number of
tissue blocks with changes in AGMLG ranged from 1 to
12 (median, 3) per case. All patients were women, ranging
in age from 38 to 93 years (median, 65 y; mean, 64.2 y).
The age of the patients was unknown in 2 cases.
All included patients were the subjects of previous
publications addressing various other clinicopathologic
aspects of AGMLG and EMPD.7,22,27–29
RESULTS
The main clinical and morphologic ﬁndings are sum-
marized in Table 1. All lesions involved the vulva other than 1
case of UDH in the perianal skin. Alterations of AGMLG
were found in 33 specimens from 31 patients. In 29 cases, the
carcinoma was conﬁned to the epidermis (in situ), whereas in
the remaining 4 there was stromal microinvasion deﬁned as
invasion to a depth of no >1mm.30 The most common
change encountered in AGMLG was CCC (87.1%) (Fig. 1).
Less frequently found were UDH (22.6%), CCH (9.7%),
oxyphilic (apocrine) metaplasia (6.5%), and ADH (3.2%)
(Figs. 2–4). Four cases (12.9%), in addition to intraepidermal
carcinoma, harbored invasive carcinoma resembling breast
carcinoma (3 with invasive carcinoma of no special type
[NST] [previously known as ductal carcinoma]; 1 with a
tubulolobular carcinoma). In all 4 cases AGMLG displayed a
range of changes including DCIS (1 case), CCC (2 cases), and
CCC combined with CCH (1 case) (Figs. 5, 6). In a further 3
cases (9.7%), DCIS without definite invasion was recognized.
In 2 of these, adjacent to DCIS were areas of fibrosis and
elastosis, as may be found in mammary invasive carcinoma,
NST (Fig. 7). DCIS morphology included solid growth with
TABLE 1. Summary of the Main Clinicopathologic Features
Type of Change in AGMLG No. Cases Other Changes in AGMLG (No. Cases) Age (y)/Median (Range)
CCC 12 — 68 (49-86)
Unknown in 1 case
CCH 2 CCC (2) 61 (57-65)
UDH 5 CCC (4), OM (1) 70 (59-93)
DCIS, G2-3 3 CCC (3), AGMLG colonization (1) 51 (40-56)
ICNST, G3, and DCIS 1 74
Invasive mammary-type carcinomas, G2-3 incl.
ICNST (2) and TLC (1)
3 CCC (3), CCH (1) 78 (38-78)
Colonization by neoplastic cells 5 CCC (3), UDH (2), ADH (1), OM (1) 51.5 (47-75)
Unknown in 1 case
ICNST indicates invasive carcinoma, no special type (previously known as invasive ductal carcinoma); OM, oxyphilic metaplasia; TLC tubulolobular carcinoma.
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or without comedonecrosis or a micropapillary pattern, and
was of grade 2 to 3. The invasive carcinomas also were grade
2 or 3. Colonization of AGMLG by neoplastic Paget cells was
noted in 6 cases (Fig. 8). In 3, single cells or small clusters
of neoplastic cells focally infiltrated the glandular portion
of AGMLG. One case each, respectively, showed extensive
single cell infiltration of neoplastic cells beneath a preserved
luminal layer in an excretory duct, similar extensive single cell
infiltration in both glandular and excretory duct elements, and
almost complete replacement of normal glandular luminal
epithelium by solid and cribriform formations of Paget cells,
with a preserved peripheral myoepithelial cell layer, occa-
sioning resemblance to DCIS. In a further case with DCIS,
there was also extensive colonization of AGMLG.
DISCUSSION
We found alterations of AGMLG in 33 of 181
specimens (18.2%) although the actual ﬁgure may be
higher, as some specimens (small biopsies) lacked
AGMLG. From our ﬁndings, there seems to be a spec-
trum of ductal lesions ranging from CCC and CCH
via UDH/ADH to DCIS and invasive carcinoma.
The question is whether this ﬁnding allows a bona ﬁde
conclusion that a subset of primary EMPD may originate
in AGMLG. Although in the breast, low level allelic
imbalance was demonstrated in columnar cell lesions,31
our recent study suggested that CCC and CCH may occur
normally in AGMLG, as they were seen in approximately
30% and 10% of cases, respectively.32 Admittedly,
no molecular biological studies were carried out for
comparison with the breast data. More remarkable is that
CCC in AGMLG in the setting of EMPD is much more
frequent than in “normal” AGMLG (87% vs. 33%,
respectively).32
FIGURE 1. A and B, CCC of AGMLG in EMPD. Note a lumen
of the gland lined by 1 to 2 cell layers of elongated to ovoid
columnar epithelial cells oriented perpendicularly to the
basement membrane, having apical cytoplasmic snouts.
FIGURE 2. UDH of AGMLG showing irregularly shaped
bridges connecting opposite portions of the wall (A) or intra-
luminal proliferations of relatively monomorphic cells (B).
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In this series, there were 4 cases of invasive
mammary-type carcinomas of AGMLG and 3 cases of
DCIS, suggesting that in these cases the carcinoma may
have originated in AGMLG, with subsequent upward
migration of the neoplastic cells into the epidermis, sim-
ilar to cases of so-called invasive MPD.7,33 In 2 of these
cases, there was elastosis near the DCIS that may be
a sign of stromal invasion analogous to the situation in
the breast in which an invasive carcinoma of NST may
elicit prominent elastosis, at times so prominent as to be
appreciated grossly as white chalky streaks. If one accepts
the occurrence of DCIS and invasive carcinoma as 1 path
of tumor progression in EMPD, then UDH and ADH
might reasonably be interpreted as precursor lesions.
In contrast, we have previously shown that cuta-
neous adnexa including hair follicles, sebaceous glands,
and apocrine and eccrine units may present a path for
carcinomatous spread into deeper tissues in cases of
EMPD, as they are involved in almost all cases.7,22
A similar situation may be presumed with respect
to AGMLG. We noticed several patterns of colonization
of AGMLG by neoplastic cells. Both ductal and/
or glandular components were focally or diﬀusely
inﬁltrated by neoplastic cells with preservation of the
normal luminal cells or, as seen in one case, there was
almost complete replacement of the normal luminal
epithelium by solid or cribriform formations of Paget
cells above a preserved peripheral myoepithelial cell
layer resembling DCIS. In the latter case, it may be
diﬃcult or impossible to determine whether DCIS is the
source of the EMPD or the result of colonization of
these glands by the neoplastic cells of EMPD. Although
we arbitrarily considered single cell spread of Paget cells
in AGMLG as colonization, we cannot completely
exclude that this may be an incipient (in situ) carci-
nomatous change within AGMLG or the result of a ﬁeld
eﬀect. One can argue that the similar occurrence in
cutaneous adnexa may occasion the same conclusion,
but the absence of lesions compatible with DCIS
in eccrine/apocrine units and involvement of diﬀerent
adnexa (sebaceous glands, hair follicles, etc.) militate
against an adnexal origin.
In conclusion, AGMLG in primary EMPD man-
ifest a range of changes analogous to those occurring in
the breast and which may be regarded as a morphologic
spectrum. As CCC and CCH may be encountered in
normal AGMLG, these alterations would seem to
play little, if any, role in the pathogenesis of EMPD.
FIGURE 3. CCH of AGMLG. Note the lumina lined by >2 cell
layers of elongated to ovoid columnar epithelial cells oriented
perpendicularly to the basement membrane, having apical
cytoplasmic snouts.
FIGURE 4. A and B, Oxyphilic metaplasia of AGMLG. Note
cells with eosinophilic, glassy cytoplasm in 2 glands (arrows).
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However, DCIS and invasive carcinoma comprising the
malignant end of the spectrum suggest, by analogy with
some cases of MPD,33 that rare cases of primary EMPD
may originate in AGMLG with subsequent upward
migration of the neoplastic cells into the epidermis and
possible later breach through the basement membrane.
UDH and ADH can then be regarded as precursor le-
sions, linking both ends of the spectrum. If our propo-
sition is conﬁrmed in subsequent studies, this may result
in a reevaluation of current therapeutic approaches to
primary EMPD, especially with respect to local surgical
and nonsurgical treatment, which should take into
consideration both the depth of secondary adnexal in-
volvement (up to 3.6mm) and the depth of location of
AGMLG (up to 3.9mm) as a possible source of disease,
including recurrences, which have a rate that ranges
currently from 12% to 57%.3,22,32
FIGURE 5. EMPD associated with underlying mammary-type
invasive carcinoma of NST (previously called invasive ductal
carcinoma) (A). Note DCIS of micropapillary type (arrows) (B).
FIGURE 6. Formations of invasive tubulolobular carcinoma
concentrically surrounding AGMLG with CCC. The invasive
carcinoma in other areas was composed of single cell cords of
round to ovoid cells intermixed with round to elongated tu-
bules showing decapitation secretion at the luminal border,
with both components positive for E-Cadherin (not shown).
Inset: higher magnification of the invasive component.
FIGURE 7. A and B, DCIS of solid type involving AGMLG with
adjacent areas of fibrosis and elastosis. Note possible micro-
invasion (B).
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FIGURE 8. Colonization of AGMLG by Paget cells. Note the
diffuse infiltration of the duct and CCC (A), and diffuse colo-
nization of the glands (B).
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